MX2012000565A - Derivados de triterpeno tipo lupeol como antivirales. - Google Patents
Derivados de triterpeno tipo lupeol como antivirales.Info
- Publication number
- MX2012000565A MX2012000565A MX2012000565A MX2012000565A MX2012000565A MX 2012000565 A MX2012000565 A MX 2012000565A MX 2012000565 A MX2012000565 A MX 2012000565A MX 2012000565 A MX2012000565 A MX 2012000565A MX 2012000565 A MX2012000565 A MX 2012000565A
- Authority
- MX
- Mexico
- Prior art keywords
- lupeol
- antivirals
- type triterpene
- triterpene derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J69/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one atom and expansion of only one ring by one atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Biotechnology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La invención se relaciona a los derivados del nuevo triterpeno tipo lupeol y compuestos relacionados y a composiciones farmacéuticas útiles para el tratamiento de las enfermedades virales y particularmente a enfermedades del VIH.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1670CH2009 | 2009-07-14 | ||
US25193309P | 2009-10-15 | 2009-10-15 | |
IN587CH2010 | 2010-03-08 | ||
PCT/IB2010/001677 WO2011007230A2 (en) | 2009-07-14 | 2010-07-05 | Lupeol-type triterpene derivatives as antivirals |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012000565A true MX2012000565A (es) | 2012-05-08 |
Family
ID=43449901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012000565A MX2012000565A (es) | 2009-07-14 | 2010-07-05 | Derivados de triterpeno tipo lupeol como antivirales. |
Country Status (10)
Country | Link |
---|---|
US (1) | US9067966B2 (es) |
EP (1) | EP2454270B1 (es) |
KR (2) | KR20140016428A (es) |
CN (1) | CN102656180B (es) |
AP (1) | AP2012006081A0 (es) |
BR (1) | BR112012000769A2 (es) |
CA (1) | CA2767642C (es) |
MX (1) | MX2012000565A (es) |
RU (1) | RU2561604C2 (es) |
WO (1) | WO2011007230A2 (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200837074A (en) | 2006-11-03 | 2008-09-16 | Panacos Pharmaceuticals Inc | Extended triterpene derivatives |
US8802727B2 (en) * | 2009-07-14 | 2014-08-12 | Hetero Research Foundation, Hetero Drugs Limited | Pharmaceutically acceptable salts of betulinic acid derivatives |
US9067966B2 (en) | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
WO2012095705A1 (en) * | 2011-01-10 | 2012-07-19 | Hetero Research Foundation | Pharmaceutically acceptable salts of novel betulinic acid derivatives |
JP6001560B2 (ja) * | 2011-01-31 | 2016-10-05 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | Hiv成熟阻害活性を有するc−17およびc−3修飾トリテルペノイド |
EP2670764B1 (en) | 2011-01-31 | 2015-09-02 | Bristol-Myers Squibb Company | C-28 amines of c-3 modified betulinic acid derivatives as hiv maturation inhibitors |
EP3597206A1 (en) | 2011-06-21 | 2020-01-22 | BVW Holding AG | Medical device comprising boswellic acid |
TW201317255A (zh) | 2011-09-21 | 2013-05-01 | 必治妥美雅史谷比公司 | 具抗病毒活性之新穎樺木酸衍生物 |
CN104271550B (zh) * | 2011-12-14 | 2016-09-07 | 葛兰素史克有限责任公司 | 白桦脂醇的丙烯酸酯衍生物 |
JO3387B1 (ar) | 2011-12-16 | 2019-03-13 | Glaxosmithkline Llc | مشتقات بيتولين |
US8906889B2 (en) | 2012-02-15 | 2014-12-09 | Bristol-Myers Squibb Company | C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |
WO2013160810A2 (en) * | 2012-04-24 | 2013-10-31 | Hetero Research Foundation | Novel betulinic acid derivatives as hiv inhibitors |
US8889854B2 (en) | 2012-05-07 | 2014-11-18 | Bristol-Myers Squibb Company | C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity |
JP2016503030A (ja) | 2012-12-14 | 2016-02-01 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC | 医薬組成物 |
US9637516B2 (en) | 2012-12-31 | 2017-05-02 | Hetero Research Foundation | Betulinic acid proline derivatives as HIV inhibitors |
EP2953960A1 (en) | 2013-02-06 | 2015-12-16 | Bristol-Myers Squibb Company | C-19 modified triterpenoids with hiv maturation inhibitory activity |
MX2015010354A (es) | 2013-02-25 | 2015-10-09 | Squibb Bristol Myers Co | Derivados de acido betulinico modificados con aquilo c-3 y alquenilo utiles en el tratamiento de virus de inmunodeficiencia humana (vih). |
WO2015157483A1 (en) | 2014-04-11 | 2015-10-15 | Bristol-Myers Squibb Company | Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent |
US9920090B2 (en) | 2014-06-19 | 2018-03-20 | VIIV Healthcare UK (No.5) Limited | Betulinic acid derivatives with HIV maturation inhibitory activity |
WO2015198263A2 (en) * | 2014-06-26 | 2015-12-30 | Hetero Research Foundation | Novel betulinic proline substituted derivatives as hiv inhibitors |
US20170129916A1 (en) | 2014-06-26 | 2017-05-11 | Hetero Research Foundation | Novel betulinic proline imidazole derivatives as hiv inhibitors |
CA2961528A1 (en) | 2014-09-26 | 2016-03-31 | Glaxosmithkline Intellectual Property (No.2) Limited | Long acting pharmaceutical compositions |
RU2017118489A (ru) | 2014-11-14 | 2018-12-14 | ВАЙВ ХЕЛТКЕР ЮКей (N5) ЛИМИТЕД | Оксолупеновые производные |
CA2967684A1 (en) | 2014-11-14 | 2016-05-19 | VIIV Healthcare UK (No.5) Limited | C17-aryl substituted betulinic acid analogs |
MA40886B1 (fr) | 2015-02-09 | 2020-03-31 | Hetero Research Foundation | Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih |
WO2016147099A2 (en) | 2015-03-16 | 2016-09-22 | Hetero Research Foundation | C-3 novel triterpenone with c-28 amide derivatives as hiv inhibitors |
WO2017021922A1 (en) * | 2015-08-05 | 2017-02-09 | Hetero Research Foundation | Novel substituted amides of triterpene derivatives as hiv inhibitors |
WO2017115329A1 (en) * | 2015-12-30 | 2017-07-06 | Hetero Research Foundation | C-3 novel triterpenone derivatives as hiv inhibitors |
AR107512A1 (es) | 2016-02-04 | 2018-05-09 | VIIV HEALTHCARE UK Nº 5 LTD | Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1 |
US20190183901A1 (en) * | 2016-08-31 | 2019-06-20 | Viiv Healthcare Company | Combinations and uses and treatments thereof |
WO2018044853A1 (en) * | 2016-08-31 | 2018-03-08 | Viiv Healthcare Conpany | Combinations and uses and treatments thereof |
RU2641900C1 (ru) * | 2017-02-27 | 2018-01-23 | Федеральное государственное автономное образовательное учреждение высшего образования "Новосибирский национальный исследовательский государственный университет" (Новосибирский государственный университет, НГУ) | N-[3-оксолуп-20(29)-ен-28-оил]-2,2,6,6-тетраметилпиперидин-4-иламин, обладающий цитотоксической активностью в отношении опухолевых клеток человека |
LT3924361T (lt) | 2019-02-11 | 2023-12-27 | Hetero Labs Limited | Nauji triterpeno dariniai kaip živ inhibitoriai |
KR102601258B1 (ko) * | 2020-02-25 | 2023-11-13 | (주)지뉴인텍 | 코로나바이러스감염증-19(covid-19)에 대한 재조합 아데노바이러스 백신 및 이를 이용한 병용요법 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58152815A (ja) | 1982-03-05 | 1983-09-10 | Tamio Nishimura | 医療用抗ウイルス剤 |
EP0724650A4 (en) | 1993-07-09 | 1998-12-02 | Univ Pittsburgh | SELECTION AND USE OF ANTIVIRAL PEPTIDES |
US5679828A (en) | 1995-06-05 | 1997-10-21 | Biotech Research Labs, Inc. | Betulinic acid and dihydrobetulinic acid derivatives and uses therefor |
WO1998046238A1 (en) | 1997-04-15 | 1998-10-22 | Medichem Research, Inc. | Biflavinoids and derivatives thereof as antiviral agents, alone or in combination with at least one known antiviral agent |
HUP9701080A3 (en) | 1997-06-23 | 1999-05-28 | Gene Res Lab Inc New York N | Pharmaceutical composition containing a compound of antiviral activity and a hydroximic acid ester derivative |
US6670345B1 (en) * | 1997-09-30 | 2003-12-30 | Dabur Research Foundation | Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid |
US6427248B1 (en) | 1997-10-09 | 2002-08-06 | David M. Albert | Grip-enhancing glove |
EP1131337B1 (en) * | 1998-11-18 | 2009-01-14 | Dabur Pharma Ltd. | Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
WO2001007646A2 (de) | 1999-07-21 | 2001-02-01 | Martin Heinkelein | Verfahren zur quantifizierung der antiviralen wirkung antiviraler wirkstoffe |
WO2002091858A1 (en) | 2001-05-11 | 2002-11-21 | University Of Ottawa | Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods |
WO2003037908A1 (en) | 2001-10-31 | 2003-05-08 | Ribapharm Inc. | Antiviral combination therapy and compositions |
RU2211843C1 (ru) * | 2002-01-25 | 2003-09-10 | Новосибирский институт органической химии им. Н.Н.Ворожцова СО РАН | N'-{n-[3-оксо-20(29)-лупен-28-оил]-9-аминононаноил}-3-амино-3-фенилпропио новая кислота, обладающая иммуностимулирующей и противовирусной активностью |
EP1594885B8 (de) | 2003-02-11 | 2009-03-25 | Novelix Pharmaceuticals, Inc. | Medikament zur wachstumsinhibierung von tumoren |
US7026305B2 (en) | 2003-04-14 | 2006-04-11 | Meharry Medical College | Anti-HIV agents with dual sites of action |
RU2387665C2 (ru) | 2004-03-17 | 2010-04-27 | Панакос Фармасьютикалз, Инк. | Фармацевтические соли 3-о-(3', 3'-диметилсукцинил)бетулиновой кислоты |
CA2585623C (en) * | 2004-10-27 | 2012-06-05 | Daiichi Sankyo Company Limited | Ortho-substituted benzene derivatives |
TW200628161A (en) | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
US20090023698A1 (en) | 2005-03-29 | 2009-01-22 | Krasutsky Pavel A | Methods of manufacturing bioactive 3-esters of betulinic aldehyde and betulinic acid |
CN101287744A (zh) | 2005-06-22 | 2008-10-15 | 美瑞德生物工程公司 | 抗病毒化合物 |
JP2008543945A (ja) | 2005-06-22 | 2008-12-04 | ミリアド ジェネティクス, インコーポレイテッド | 抗ウイルス化合物 |
CN100475835C (zh) | 2006-05-12 | 2009-04-08 | 中国药科大学 | 23-羟基白桦酸类衍生物、其制备方法、制剂及用途 |
FI20065389A (fi) | 2006-06-07 | 2007-12-31 | Valtion Teknillinen | Betuliiniperäiset yhdisteet kasvien tuholaisten syönnin estäjinä |
FI121468B (fi) | 2006-06-07 | 2010-11-30 | Valtion Teknillinen | Betuliiniperäiset yhdisteet antimikrobisina aineina |
WO2008127364A2 (en) | 2006-10-13 | 2008-10-23 | Myriad Genetics, Inc. | Antiviral compounds and use thereof |
WO2008115281A2 (en) * | 2006-10-16 | 2008-09-25 | Myriad Genetics, Inc. | Compounds for treating viral infections |
TW200837074A (en) | 2006-11-03 | 2008-09-16 | Panacos Pharmaceuticals Inc | Extended triterpene derivatives |
US20110152229A1 (en) * | 2006-11-22 | 2011-06-23 | Duke University | Betulinic acid derivatives as anti-hiv agents |
WO2008091532A1 (en) | 2007-01-19 | 2008-07-31 | Panacos Pharmaceuticals, Inc. | Salts of 3-o-(3',3'-dimethylsuccinyl)betulinic acid and solid state forms thereof |
WO2009082818A1 (en) | 2008-01-03 | 2009-07-09 | Virochem Pharma Inc. | Novel c-21-keto lupane derivatives preparation and use thereof |
CA2711424A1 (en) | 2008-01-03 | 2009-07-09 | Virochem Pharma Inc. | Novel lupane derivatives |
AU2009214779A1 (en) | 2008-02-14 | 2009-08-20 | Virochem Pharma Inc. | Novel 17beta lupane derivatives |
WO2010132334A1 (en) | 2009-05-15 | 2010-11-18 | The University Of North Carolina At Chapel Hill | 3,28-disubstituted betulinic acid derivatives as anti-hiv agents |
US9067966B2 (en) | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
US8802727B2 (en) | 2009-07-14 | 2014-08-12 | Hetero Research Foundation, Hetero Drugs Limited | Pharmaceutically acceptable salts of betulinic acid derivatives |
WO2012095705A1 (en) | 2011-01-10 | 2012-07-19 | Hetero Research Foundation | Pharmaceutically acceptable salts of novel betulinic acid derivatives |
-
2010
- 2010-07-02 US US12/829,483 patent/US9067966B2/en not_active Expired - Fee Related
- 2010-07-05 MX MX2012000565A patent/MX2012000565A/es not_active Application Discontinuation
- 2010-07-05 KR KR1020147000436A patent/KR20140016428A/ko not_active Application Discontinuation
- 2010-07-05 EP EP10734556.3A patent/EP2454270B1/en not_active Not-in-force
- 2010-07-05 AP AP2012006081A patent/AP2012006081A0/xx unknown
- 2010-07-05 WO PCT/IB2010/001677 patent/WO2011007230A2/en active Application Filing
- 2010-07-05 CA CA2767642A patent/CA2767642C/en not_active Expired - Fee Related
- 2010-07-05 BR BR112012000769A patent/BR112012000769A2/pt not_active IP Right Cessation
- 2010-07-05 RU RU2012104993/04A patent/RU2561604C2/ru not_active IP Right Cessation
- 2010-07-05 CN CN201080031744.XA patent/CN102656180B/zh not_active Expired - Fee Related
- 2010-07-05 KR KR1020127003716A patent/KR101582856B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US9067966B2 (en) | 2015-06-30 |
KR101582856B1 (ko) | 2016-01-07 |
CA2767642C (en) | 2014-11-18 |
WO2011007230A3 (en) | 2011-06-03 |
KR20140016428A (ko) | 2014-02-07 |
RU2561604C2 (ru) | 2015-08-27 |
EP2454270A2 (en) | 2012-05-23 |
CN102656180A (zh) | 2012-09-05 |
WO2011007230A2 (en) | 2011-01-20 |
KR20120037985A (ko) | 2012-04-20 |
RU2012104993A (ru) | 2013-08-20 |
AP2012006081A0 (en) | 2012-02-29 |
CN102656180B (zh) | 2016-04-20 |
US20110015196A1 (en) | 2011-01-20 |
BR112012000769A2 (pt) | 2016-02-23 |
EP2454270B1 (en) | 2015-02-11 |
CA2767642A1 (en) | 2011-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2012000565A (es) | Derivados de triterpeno tipo lupeol como antivirales. | |
IN2012DN00971A (es) | ||
PH12015500274A1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
PH12015500713A1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
CA2883210C (en) | Bicyclic aza compounds as muscarinic m1 receptor agonists | |
IN2012DN02805A (es) | ||
MD4754B1 (ro) | Compuşi policiclici de carbamoilpiridonă şi utilizarea lor farmaceutică | |
MY166557A (en) | Quinazoline derivatives for the treatment of viral infections and further diseases | |
MX2020011251A (es) | Compuestos antivirales. | |
MY151246A (en) | Benzofuranyl derivatives | |
GB2511685A (en) | Muscarinic m1 receptor agonists | |
PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
ZA201108305B (en) | Novel p2x7r antagonists and their use | |
IN2012DN02139A (es) | ||
PH12017550077A1 (en) | C-3 novel triterpenone with c-17 reverse amide derivatives as hiv inhibitors | |
MY164842A (en) | Isoxazolidine derivatives | |
TN2014000112A1 (en) | Ep1 receptor ligands | |
GEP20135832B (en) | Benzothiazines derivatives, preparation thereof, and their application as drugs | |
WO2015198263A3 (en) | Novel betulinic proline substituted derivatives as hiv inhibitors | |
MX2010004620A (es) | Derivados de benzomorfolina y metodos de uso. | |
WO2016147099A3 (en) | C-3 novel triterpenone with c-28 amide derivatives as hiv inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |